Long-Standing Diabetes Significantly Increases Dementia Risk in Heart Attack Survivors, Study Finds We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
A three-minute test could play a role in diagnosing people at risk of developing dementia, spotting signs of cognitive decline years before other approaches, say researchers from the UK. The Fastball test asks people to remember a stream of images viewed on a screen whilst wearing an electroencephalogram (EEG) headset, and analyses the brain’s ability…
Omega-3’s could protect women against Alzheimer’s: Study We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Eisai and Biogen have won FDA approval for a subcutaneous injection version of Leqembi that could help accelerate uptake of the Alzheimer’s disease therapy. The green light for Leqembi Iqlik (lecanemab) means it can be used as an alternative to infusions during the maintenance phase of treatment with the anti-amyloid therapy, and patients will still…
Biogen, Eisai get USFDA nod for Leqembi Iqlik Subcutaneous Injection for maintenance dosing for early Alzheimer’s Disease We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Hormone therapy type matters for memory performance after menopause, reveals study We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Germany and Austria are the first countries in the EU to see the launch of Leqembi, Eisai and Biogen’s much-delayed drug for early-stage Alzheimer’s disease. Anti-amyloid antibody Leqembi (lecanemab) made its EU debut in Austria yesterday and will be introduced in Germany on Monday (1st September), becoming the first drug in the class to reach…
Heart-healthy habits also prevent cancer, Alzheimer’s, COPD, other diseases, Emory study finds We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Women with Down Syndrome More Vulnerable to Alzheimer’s Than Men: Study Finds We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Sanofi completes acquisition of Vigil Neuroscience We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link